Bidirectional Regulation of NLRP3 Inflammasome and Mitochondrial Quality Control in Sepsis: Mechanisms and Therapeutic Implications
Top Cited Papers
Open Access
- 28 January 2026
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Abstract
Characterized by its capacity to induce organ failure, sepsis constitutes a life‐threatening pathological state with high incidence and mortality rates. Current treatments primarily focus on antimicrobial therapy and organ support, lacking direct interventions targeting the restoration of cellular or organelle function. Among these mechanisms, mitochondrial dysfunction and overactivation of the NLR family pyrin domain‐containing 3 (NLRP3) inflammasome stand out as key pathological hallmarks. As a classic inflammasome, the NLRP3 inflammasome, upon activation, drives cellular pyroptosis and massive release of inflammatory mediators. Beyond their role as cellular energy generators, mitochondria participate in the modulation of inflammatory responses and oxidative stress control. Mitochondrial quality control (MQC) serves as a prerequisite for the orderly performance of mitochondrial physiological functions. Disruption of MQC invariably results in mitochondrial dysfunction, triggering liberation of mitochondrial reactive oxygen species (mtROS) along with mitochondrial damage‐associated molecular patterns (mtDAMPs), which serve as direct triggers for NLRP3 inflammasome formation and stimulation. This process disrupts MQC, exacerbates mitochondrial dysfunction, and forms a mutually reinforcing “MQC imbalance‐NLRP3 overactivation” vicious cycle that drives disease progression. This review aims to: (1) systematically elucidate the complex bidirectional regulatory mechanisms between the NLRP3 inflammasome and MQC in the context of sepsis, (2) summarize the latest research progress on targeted intervention strategies based on this vicious cycle, and (3) discuss the challenges in clinical translation and future directions of these strategies.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7232126)
This publication has 177 references indexed in Scilit:
- Oxidative stress and endothelial dysfunction during sepsisFrontiers in Bioscience-Landmark, 2011
- Survival in Critical Illness Is Associated with Early Activation of Mitochondrial BiogenesisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Dynamic regulation of mitochondrial fission through modification of the dynamin‐related protein Drp1Annals of the New York Academy of Sciences, 2010
- Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted AntioxidantsInfectious Disorders - Drug Targets, 2009
- Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent modelsJournal of Clinical Investigation, 2009
- Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1β, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemiaIntensive Care Medicine, 2007
- Role of the mitochondrial membrane permeability transition in cell deathApoptosis, 2006
- Clinical Implications of Mitochondrial DysfunctionAnesthesiology, 2006
- Association between mitochondrial dysfunction and severity and outcome of septic shockThe Lancet, 2002
- Caspase‐1‐inhibitor ac‐YVAD‐cmk reduces LPS‐lethality in rats without affecting haematology or cytokine responsesBritish Journal of Pharmacology, 2000